Artículos científicos Open Access

In favour of a bespoke COVID-19 vaccines compensation scheme
The Lancet Infectious Diseases
Duncan Fairgrieve, Søren Holm, Geraint Howells, Claas Kirchhelle, Samantha Vanderslott
Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
The Lancet Gastroenterology & Hepatology
Lucie de Jonge, Joachim Worthington, Francine van Wifferen, Nicolas Iragorri, Elisabeth F P Peterse, Jie-Bin Lew, and others
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
The Lancet Rheumatology
Giulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, Corrado Campochiaro, Emanuel Della-Torre, Giacomo De Luca, and others
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
The Lancet
Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov, Amir I Tukhvatulin, Olga V Zubkova, Alina S Dzharullaeva, and others
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study
The Lancet Infectious Diseases
Michael Marks, et al
Understanding the drivers of transmission of SARS-CoV-2
The Lancet Infectious Diseases
Laura Cornelissen, Emmanuel André
COVID-19, structural racism, and migrant health in Canada
The Lancet
Germaine Tuyisenge, Shira M Goldenberg

Página 208 de 490

Síguenos en nuestras redes sociales

Suscríbete a nuestro Boletín Institucional
INSP logo
© 2022 INSP. Todos los derechos reservados.